Ludwig Boltzmann Institute for Lung Vascular Research, Stiftingtalstrasse 24, 8010, Graz, Austria.
Int J Cardiovasc Imaging. 2013 Dec;29(8):1871-8. doi: 10.1007/s10554-013-0279-6. Epub 2013 Aug 23.
Cardiac output (CO) is an important diagnostic and prognostic factor in the haemodynamic evaluation of patients. The gold standard for CO measurement, thermodilution, requires an invasive right-heart catheterisation (RHC). In this pilot study we aimed to determine the accuracy of non-invasive CO determination from dynamic contrast-enhanced computed tomography (CT) compared to thermodilution. Patients who underwent diagnostic or follow-up RHC due to suspected or known pulmonary vascular disease at our department and required a thoracic CT between June 2011 and August 2012 were included. CO was determined from CT attenuation-time curves in the pulmonary artery and the ascending aorta using a dynamic contrast-enhanced CT sequence. CO determined in N = 18 patients by dynamic CT in the pulmonary artery was in very good agreement with thermodilution data (r = 0.84). Bland-Altman analysis showed a systematic overestimation of 0.7 ± 0.6 l/min compared to thermodilution. Data from the ascending aorta also showed a good correlation, but with a larger scattering of the values. The average effective dose for the dynamic investigation was 1.2 ± 0.7 mSv. CO determined with dynamic contrast-enhanced CT in the main pulmonary artery reliably predicts the values obtained by thermodilution during RHC. This non-invasive technique might provide an alternative for repeated invasive right-heart catheter investigations in the follow-up of pulmonary arterial hypertension patients.
心输出量(CO)是血液动力学评估患者的重要诊断和预后因素。CO 测量的金标准是热稀释法,需要进行有创的右心导管检查(RHC)。在这项初步研究中,我们旨在确定与热稀释法相比,从动态对比增强 CT(CT)非侵入性 CO 测定的准确性。本研究纳入了 2011 年 6 月至 2012 年 8 月期间因疑似或已知肺血管疾病而在我院接受诊断性或随访性 RHC 且需要进行胸部 CT 的患者。通过动态对比增强 CT 序列,从肺动脉和升主动脉的 CT 衰减时间曲线中确定 CO。18 例患者的 CO 通过肺动脉动态 CT 确定,与热稀释数据非常吻合(r=0.84)。Bland-Altman 分析显示,与热稀释相比,存在 0.7±0.6l/min 的系统高估。升主动脉的数据也显示出良好的相关性,但值的离散度较大。动态研究的平均有效剂量为 1.2±0.7mSv。主肺动脉的动态对比增强 CT 测定的 CO 可靠地预测了 RHC 期间热稀释法获得的值。这种非侵入性技术可能为肺动脉高压患者的随访提供重复有创右心导管检查的替代方法。